In the massive litigation over side effects from the diabetes drug Avandia, a federal judge has dismissed all claims brought by insurers acting as "Medicare Advantage Organizations" or MAOs that demanded reimbursements from the settlements paid out by the drug’s maker, GlaxoSmithKline.
In the suit, Humana Medical Plan Inc. sought to represent a class of MAOs whose enrollees received treatment for Avandia-related injuries and who have since settled — or will in the future settle — with GSK.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
